Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Muscle Supplement Shown Safe, Active in Elderly

A clinical trial testing a dietary supplement to improve muscle function in older persons shows the derivative from pomegranates is safe and produces desired biological actions. . . . → Read More: Muscle Supplement Shown Safe, Active in Elderly

FDA Warns Cancer Fraud Product Providers

The Food and Drug Administration sent warning letters to 14 companies in the U.S. that the agency says are selling products fraudulently claiming to prevent, diagnose, treat, or cure cancer. . . . → Read More: FDA Warns Cancer Fraud Product Providers

Research, Medical Groups Join Science March

A collection of 25 organizations representing a range of medical research and practice disciplines announced their participation in the March for Science set for Saturday, 22 April. . . . → Read More: Research, Medical Groups Join Science March

Factors IDed Boosting Post-Surgical Opioid Risk

An analysis of insurance claims identifies risk factors behind a sizeable number of people undergoing surgery becoming persistent users of opioid pain drugs long after their procedures. . . . → Read More: Factors IDed Boosting Post-Surgical Opioid Risk

FDA, Emulate to Test Organs-on-Chips for Drug Toxins

A joint venture between Food and Drug Administration and a developer of chip devices simulating human organs, is evaluating the chips as a way to test new drugs for toxic effects. . . . → Read More: FDA, Emulate to Test Organs-on-Chips for Drug Toxins

Phones, Algorithms Boost Adherence to Stroke Meds

Results from a clinical trial show a smartphone-based remote monitoring program helps stroke patients stay on their blood clot medications and improve their health. . . . → Read More: Phones, Algorithms Boost Adherence to Stroke Meds

FDA Shown Approving New Drugs Faster than Europe

An analysis of regulatory actions in the U.S. and Europe, shows the U.S. Food and Drug Administration approves more new therapies and faster than the European Medicines Agency. . . . → Read More: FDA Shown Approving New Drugs Faster than Europe

Triple-Drug Inhaler Shown to Cut COPD Attacks

Results from a year-long clinical trial show that an inhaler with three types of drugs reduces the number of COPD attacks compared to a common single-drug inhaler. . . . → Read More: Triple-Drug Inhaler Shown to Cut COPD Attacks

Zika DNA Vaccine Begins Clinical Trial

A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease. . . . → Read More: Zika DNA Vaccine Begins Clinical Trial

FDA Approves Multiple Sclerosis Therapy

The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease. . . . → Read More: FDA Approves Multiple Sclerosis Therapy